Latest Delsym Stories
Cold Buster, New Product from Buster Brands, Emerges in the Wake of Dextromethorphan Debate On the heels of an FDA Advisory Committee Meeting evaluating safety concerns of cold medication dextromethorphan, Buster Brands announces Cold Buster, a new product with proven efficacy and no risks of abuse. Morristown, NJ (Vocus) October 19, 2010 (Vocus) October 19, 2010 -- On September 14, 2010, the FDA Drug Safety and Risk Management Advisory Committee met to evaluate the safety of...
SOUTH BRUNSWICK, N.J., July 16 /PRNewswire/ -- Tris Pharma, Inc., a drug delivery and specialty pharmaceutical company, today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S.
CHESTER, N.J., July 23 /PRNewswire-FirstCall/ -- Adams Respiratory Therapeutics, Inc. today announced that both Mucinex(R) (600 mg guaifenesin extended-release bi-layer tablets) and Delsym(R) (dextromethorphan polistirex) brands ranked No.
- A transitional zone between two communities containing the characteristic species of each.